Pharma is pouring billions into AI. The biggest returns may take years to prove.
McKinsey's Guang Yang and the Pistoia Alliance's Christian Baber on why pharma's AI bets face slow feedback, trust gaps and hard culture change.
McKinsey's Guang Yang and the Pistoia Alliance's Christian Baber on why pharma's AI bets face slow feedback, trust gaps and hard culture change.